Study finds incentive payments for Ontario FPs may have unintended results NDP unveils universal pharmacare plan, aims program delivery by the end of 2020 Canada to study the safety and effectiveness of biosimilars compared to reference biologic drugs Five-year study will examine real-world comparative efficacy and safety in rheumatologic conditions and inflammatory bowel disease. Does hybrid healthcare improve public health services? Lessons learned from Australia Male FPs out-earn women FPs annually by over 30%: Ontario data Robot simulates touch of skin to reduce pain for premature babies How Big Pharma donations may influence public drug coverage A new review of 372 submissions to the Canadian Agency for Drugs or Technology in Health revealed 1896 conflicts of interest Toronto General makes Newsweek list of world’s top 10 hospitals Study says B.C.'s housing policies mean drug users can be targeted for eviction Cross-reactivity between antibacterial and nonantibacterial sulfonamides Patients with a history of sulfonamide antibiotic hypersensitivity do not need to avoid taking nonantibacterial sulfonamides First Previous 327 328 329 330 331 Next Last
